Atrial natriuretic peptide protects against histamine-induced endothelial barrier dysfunction in vivo

Molecular Pharmacology
Robert FürstAngelika M Vollmar

Abstract

Endothelial barrier dysfunction is a hallmark of many severe pathologies, including sepsis or atherosclerosis. The cardiovascular hormone atrial natriuretic peptide (ANP) has increasingly been suggested to counteract endothelial leakage. Surprisingly, the precise in vivo relevance of these observations has never been evaluated. Thus, we aimed to clarify this issue and, moreover, to identify the permeability-controlling subcellular systems that are targeted by ANP. Histamine was used as important pro-inflammatory, permeability-increasing stimulus. Measurements of fluorescein isothiocyanate (FITC)-dextran extravasation from venules of the mouse cremaster muscle and rat hematocrit values were performed to judge changes of endothelial permeability in vivo. It is noteworthy that ANP strongly reduced the histamine-evoked endothelial barrier dysfunction in vivo. In vitro, ANP blocked the breakdown of transendothelial electrical resistance (TEER) induced by histamine. Moreover, as judged by immunocytochemistry and Western blot analysis, ANP inhibited changes of vascular endothelial (VE)-cadherin, beta-catenin, and p120(ctn) morphology; VE-cadherin and myosin light chain 2 (MLC2) phosphorylation; and F-actin stress fiber formation. Thes...Continue Reading

References

May 15, 1991·Biochemical and Biophysical Research Communications·Y MorishitaY Matsuda
Aug 1, 1991·Journal of Molecular and Cellular Cardiology·C E LoftonW H Newman
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D A BaronM G Currie
Feb 1, 1987·Circulation Research·V H HuxleyR H Freeman
Jul 1, 1997·The American Journal of Physiology·K SahlinK Hirakoba
Jul 13, 2000·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·T Volk, W J Kox
Nov 8, 2001·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·P Poredos
Jun 28, 2002·Annals of Biomedical Engineering·Olakunle OgunrinadeGeorge A Truskey
Jul 24, 2002·Biochemical and Biophysical Research Communications·Alexandra K KiemerAngelika M Vollmar
May 16, 2003·Vascular Pharmacology·Geerten P van Nieuw Amerongen, Victor W M van Hinsbergh
Sep 10, 2003·Journal of Leukocyte Biology·Nina C WeberAlexandra K Kiemer
Dec 25, 2004·American Journal of Physiology. Lung Cellular and Molecular Physiology·D C IrwinR Bowen
Jan 11, 2005·Current Medicinal Chemistry. Cardiovascular and Hematological Agents·Alexandra K KiemerAngelika M Vollmar
Jun 3, 2005·The Journal of Clinical Investigation·Karim SabraneMichaela Kuhn
Dec 15, 2005·High Altitude Medicine & Biology·David C IrwinRichard Bowen
Dec 24, 2005·Physiological Reviews·Dolly Mehta, Asrar B Malik
May 6, 2006·The Journal of Physiology·Takuya HatakeyamaWalter N Durán
Sep 30, 2006·Endocrinology·Kathrin Ladetzki-BaehsAngelika M Vollmar

❮ Previous
Next ❯

Citations

Apr 23, 2013·Pflügers Archiv : European journal of physiology·Kavisha AroraAnjaparavanda P Naren
May 21, 2013·Antiviral Research·Susan M ArmstrongWarren L Lee
Mar 25, 2009·Pharmacology & Therapeutics·Emily J Tsai, David A Kass
Feb 28, 2013·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Nadezhda N BarvitenkoOguz K Baskurt
Jan 10, 2012·British Journal of Pharmacology·Michaela Kuhn
May 15, 2013·Biochemical and Biophysical Research Communications·Sony MaharjanYoung-Guen Kwon
Nov 17, 2011·Journal of Molecular and Cellular Cardiology·Martin F BubikRobert Fürst
Dec 29, 2011·The American Journal of Pathology·Susan M ArmstrongWarren L Lee
May 1, 2010·Expert Review of Clinical Pharmacology·Ryuji InoueYuko Imai
Dec 29, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Michael C HornburgerRobert Fürst
Jan 31, 2014·American Journal of Physiology. Cell Physiology·Mais AbsiDonald T Ward
Mar 25, 2009·Current Opinion in Anaesthesiology·Gianmarco M BalestraCan Ince
Mar 17, 2021·Clinical Reviews in Allergy & Immunology·Márta L DebreczeniLászló Cervenak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.